ArticleBMC urology2026
Association between hepatitis C virus and overactive bladder: a cross-sectional study based on the 2013-2018 NHANES.
Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundsOveractive bladder (OAB) is a common urological disorder with an incompletely understood pathogenesis that markedly impacts patients' quality of life, and hepatitis C virus (HCV) infection is associated with systemic inflammation and extrahepatic complications, with their potential association remaining understudied. This study thus aims to investigate the association between HCV and OAB in adults. This study aims to investigate the association between hepatitis C virus (HCV) and overactive bladder (OAB) in adults.
methodsThis study analyzed data from the National Health and Nutrition Examination Survey (NHANES) conducted between 2013 and 2018. Logistic regression analysis, subgroup analysis, and interaction tests were employed to assess the association between HCV and OAB. Additionally, propensity score matching (PSM), inverse probability weighting (IPTW), and overlap weighting (OW) were employed to control for confounding factors. E-value analysis was conducted to assess the robustness of results against unmeasured confounders, while sensitivity and specificity analyses evaluated the predictive performance of HCV for OAB.
resultsThis study included 14,012 patients aged ≥ 20 years. Logistic regression analysis demonstrated an association between HCV and OAB (OR = 2.06, 95% CI 1.46-2.90, p < 0.001). Subgroup analyses and interaction tests confirmed that the relationship between HCV and OAB remained consistent across all subgroups (all interaction P values > 0.05). After PSM, IPTW, and OW analyses, the association between the two remained significant; E-value analysis demonstrated strong robustness to unmeasured confounders; Sensitivity and specificity results indicate that HCV has predictive value for OAB.
conclusionsThe findings of this study indicate that there is a significant correlation between HCV and OAB.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.